Ishigaki, Keiko
Takeuchi, Atsuko
Taniguchi-Ikeda, Mariko
Sato, Takatoshi
Murakami, Terumi
Shichiji, Minobu
Ishiguro, Kumiko
Kihara, Yuki
Nagata, Satoru
Urade, Yoshihiro
Funding for this research was provided by:
MEXT KAKENHI (JP 16K10001, 23K21430)
Japan Agency for Medical Research and Development (23ek0109611h0002)
SHISEIKAI Scientific Award (N/A)
Article History
Received: 22 August 2024
Accepted: 21 February 2025
First Online: 26 February 2025
Declarations
:
: Keiko Ishigaki has received research grants from Sarepta Therapeutics, Inc. (clinical trial), Taiho Pharmaceutical Company, Ltd. (clinical trial), and Nippon Shinyaku Co. Ltd. (clinical trial).The other authors declare no competing interests.